Smart ring maker Oura and glucose monitoring giant Dexcom just struck a partnership that will allow the companies' products to work together, with the goal being to help users see how nutrition ...

Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the ...

65 percent of medical practices state that the proportion of sample 16 forms for all prescriptions is no more than a quarter. The launch of the electronic prescription for narcotics has been ...

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products. Dexcom is ...

Earlier this year, Dexcom won US regulatory approval to sell the Stelo glucose monitor, a prescription-free, shoulder-worn continuous tracker that costs $99 per pair and provides data via a mobile app ...

Oura is partnering with medical device maker Dexcom to integrate data from glucose biosensors with the Oura Ring, which tracks sleep, heart rate and activity. Oura also picked up $75 million from ...

Dexcom continues to offer its leading CGM systems, along with Stelo, its recently launched over-the-counter glucose biosensor. Combining its OTC CGM offering with the retail-available Oura Ring ...

Dexcom makes continuous glucose monitoring devices, including a prescription-free device named Stelo. The two companies plan to integrate glucose monitoring data from Dexcom's machines and app ...